• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

年龄与合并症之间的相互作用作为根治性前列腺切除术后死亡率的预测因素。

Interaction between age and comorbidity as predictors of mortality after radical prostatectomy.

作者信息

Froehner Michael, Koch Rainer, Litz Rainer J, Hakenberg Oliver W, Oehlschlaeger Sven, Wirth Manfred P

机构信息

Department of Urology, University Hospital Carl Gustav Carus, Technical University of Dresden, Dresden, Germany.

出版信息

J Urol. 2008 May;179(5):1823-9; discussion 1829. doi: 10.1016/j.juro.2008.01.023. Epub 2008 Mar 19.

DOI:10.1016/j.juro.2008.01.023
PMID:18355873
Abstract

PURPOSE

We identified an age range in which comorbidity is most closely associated with premature mortality after radical prostatectomy.

MATERIALS AND METHODS

A total of 1,302 patients selected for radical prostatectomy were stratified according to the Charlson score, the American Society of Anesthesiologists physical status classification, the New York Heart Association classification of heart insufficiency and the classification of angina pectoris of the Canadian Cardiovascular Society. Furthermore, patients were subdivided into several age groups. Comorbid mortality and overall mortality were the study end points. The prognostic relevance of the comorbidity classifications was assessed by comparing Mantel-Haenszel HRs, p values and 10-year overall survival rates.

RESULTS

The discriminative capacity of all 4 investigated comorbidity classifications decreased when patients 70.0 years or older were included with decreasing HRs and increasing p values. Except for the American Society of Anesthesiologists classification HRs for comparing the high vs low risk groups tended to decrease and p values simultaneously tended to increase when patients younger than 63.0 years were included. In the age range of between 63.0 and 69.9 years 10-year overall survival rates differed by 14% to 28% between patients with a high vs low comorbid risk compared with 6% to 13% in the whole sample.

CONCLUSIONS

The discriminative capacity of the investigated comorbidity classifications was greatest in the age group that was 63.0 to 69.9 years old. In patients younger than 63.0 or older than 70.0 years comorbidity classification seemed to contribute little to the prediction of comorbid mortality.

摘要

目的

我们确定了一个年龄范围,在此范围内合并症与根治性前列腺切除术后过早死亡的关联最为密切。

材料与方法

选取1302例行根治性前列腺切除术的患者,根据查尔森评分、美国麻醉医师协会身体状况分类、纽约心脏协会心力衰竭分类以及加拿大心血管学会心绞痛分类进行分层。此外,将患者细分为几个年龄组。合并症死亡率和总死亡率为研究终点。通过比较曼特尔 - 亨泽尔风险比(HRs)、p值和10年总生存率来评估合并症分类的预后相关性。

结果

当纳入70.0岁及以上患者时,所有4种研究的合并症分类的鉴别能力均下降,HRs降低,p值升高。除美国麻醉医师协会分类外,当纳入年龄小于63.0岁的患者时,比较高风险组与低风险组的HRs往往降低,而p值同时往往升高。在63.0至69.9岁的年龄范围内,合并症高风险患者与低风险患者的10年总生存率相差14%至28%,而在整个样本中这一差值为6%至13%。

结论

所研究的合并症分类在63.0至69.9岁年龄组中的鉴别能力最强。在年龄小于63.0岁或大于70.0岁的患者中,合并症分类似乎对合并症死亡率的预测作用不大。

相似文献

1
Interaction between age and comorbidity as predictors of mortality after radical prostatectomy.年龄与合并症之间的相互作用作为根治性前列腺切除术后死亡率的预测因素。
J Urol. 2008 May;179(5):1823-9; discussion 1829. doi: 10.1016/j.juro.2008.01.023. Epub 2008 Mar 19.
2
Comorbidity is poor predictor of survival in patients undergoing radical prostatectomy after 70 years of age.合并症对70岁以上接受根治性前列腺切除术患者的生存情况而言,是一个不佳的预测指标。
Urology. 2006 Sep;68(3):583-6. doi: 10.1016/j.urology.2006.03.050. Epub 2006 Sep 18.
3
Feasibility and limitations of comorbidity measurement in patients undergoing radical prostatectomy.根治性前列腺切除术患者共病测量的可行性与局限性
Eur Urol. 2005 Feb;47(2):190-5; discussion 195. doi: 10.1016/j.eururo.2004.07.031.
4
Detailed analysis of Charlson comorbidity score as predictor of mortality after radical prostatectomy.对Charlson合并症评分作为根治性前列腺切除术后死亡率预测指标的详细分析。
Urology. 2008 Dec;72(6):1252-7. doi: 10.1016/j.urology.2008.05.037. Epub 2008 Aug 23.
5
Comparison of tumor- and comorbidity-related predictors of mortality after radical prostatectomy.根治性前列腺切除术后肿瘤及合并症相关死亡预测因素的比较
Scand J Urol Nephrol. 2005;39(6):449-54. doi: 10.1080/00365590510031174.
6
Which comorbidity classification best fits elderly candidates for radical prostatectomy?哪种合并症分类最适合接受根治性前列腺切除术的老年患者?
Urol Oncol. 2013 May;31(4):461-7. doi: 10.1016/j.urolonc.2011.03.002. Epub 2011 Apr 16.
7
Changing comorbidity classification patterns at radical prostatectomy during a 10-year period.10年间根治性前列腺切除术时合并症分类模式的变化
Urol Oncol. 2007 Jan-Feb;25(1):26-31. doi: 10.1016/j.urolonc.2006.02.004.
8
Nomogram underestimates 10-year survival in healthy men selected for radical prostatectomy at age 70 years or older.列线图低估了70岁及以上接受根治性前列腺切除术的健康男性的10年生存率。
Urology. 2009 Mar;73(3):610-3; discussion 613-4. doi: 10.1016/j.urology.2008.09.084. Epub 2009 Jan 23.
9
30-day mortality and major complications after radical prostatectomy: influence of age and comorbidity.前列腺癌根治术后30天死亡率及主要并发症:年龄和合并症的影响
J Natl Cancer Inst. 2005 Oct 19;97(20):1525-32. doi: 10.1093/jnci/dji313.
10
Survival benefit of radical prostatectomy in patients with localized prostate cancer: estimations of the number needed to treat according to tumor and patient characteristics.根治性前列腺切除术治疗局限性前列腺癌的生存获益:根据肿瘤和患者特征估计的需要治疗的人数。
J Urol. 2012 Jul;188(1):73-83. doi: 10.1016/j.juro.2012.03.005. Epub 2012 May 12.

引用本文的文献

1
Patient characteristics predicting prolonged length of hospital stay following robotic-assisted radical prostatectomy.预测机器人辅助根治性前列腺切除术后住院时间延长的患者特征。
Ther Adv Urol. 2022 Mar 18;14:17562872221080737. doi: 10.1177/17562872221080737. eCollection 2022 Jan-Dec.
2
Impact of the ASA Physical Status Score on Adjuvant Chemotherapy Eligibility and Survival of Upper Tract Urothelial Carcinoma Patients: a Multicenter Study.美国麻醉医师协会身体状况评分对输尿管上皮癌患者辅助化疗资格及生存的影响:一项多中心研究
J Korean Med Sci. 2017 Feb;32(2):335-342. doi: 10.3346/jkms.2017.32.2.335.
3
The influence of comorbidities on overall survival among older women diagnosed with breast cancer.
患有乳腺癌的老年女性合并症对总生存的影响。
J Natl Cancer Inst. 2011 Jul 20;103(14):1101-11. doi: 10.1093/jnci/djr188. Epub 2011 Jun 30.
4
Patients with localised prostate cancer (t1 - t2) show improved overall long-term survival compared to the normal population.局限性前列腺癌(t1-t2)患者的总体长期生存率优于普通人群。
J Cancer. 2011 Feb 8;2:76-80. doi: 10.7150/jca.2.76.
5
[Social gradient of PSA screening? 8 years follow up from the cancer registry of the tumor center in Regensburg].[前列腺特异性抗原(PSA)筛查的社会梯度?来自雷根斯堡肿瘤中心癌症登记处的8年随访]
Urologe A. 2010 Dec;49(12):1503-7. doi: 10.1007/s00120-010-2425-2.
6
Prediction of mortality after radical prostatectomy by Charlson comorbidity index.基于 Charlson 合并症指数预测根治性前列腺切除术后的死亡率。
Urology. 2010 Sep;76(3):553-7. doi: 10.1016/j.urology.2010.02.069.